drugset / Trial / NCT00870480
A Relative Bioavailability Study of Finasteride 5 mg Tablets Under Fasting Conditions
RandomizedCrossoverOpen-label
Summary
The purpose of this study to compare the rate and extent of absorption of Actavis Group hf, Iceland, finasteride and Merck \& Co. Inc., U.S.A. (Proscar), finasteride, administered as a 1 x 5 mg tablet, under fasting conditions.
Timeline
- Start
- 2004-11
- Primary completion
- 2004-11
- Completion
- 2004-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Finasteride | Small molecule | 5 mg | — |
Indications
No indication recorded.